Department of Health
Medicaid Prescription Drug Rebates (Follow-Up Report) The states can receive rebates from drug manufacturers for prescription drugs provided to Medicaid recipients. In audit report 2005-S-51, we examined the progress made by the Department in improving its rebate collection efforts. We found that some improvements had been made, but the Department had not fully implemented its new system for billing, tracking and accounting for rebates. We also examined other actions taken by the Department to reduce the overall cost of Medicaid prescription drugs, which account for about 15 percent of New York State’s total Medicaid costs, and found that the implementation of several possible cost-saving measures had been delayed. When we followed up on our prior audit recommendations, we found that they had been implemented by the Department.
For a complete copy of Report 2008-F-2 click here.
For a copy of the 90-day response click here.